Investigación clínica por ciudad y condición

Ensayos clínicos de cáncer en Monterrey

Estudios oncológicos con sedes declaradas en la ciudad. Los protocolos pueden diferenciar por tipo de tumor, etapa, biomarcadores y tratamientos previos.

Estudios detectados51
Sedes identificables59
CiudadMonterrey
Revisión2026-09-26
Alcance: estos conteos reflejan registros Recruiting o Not Yet Recruiting con al menos una sede declarada en la ciudad. No sustituyen COFEPRIS/RNEC ni confirman disponibilidad inmediata de cupo.

Estudios registrados

ReclutandoNCT03486873

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Fase 3Merck Sharp & Dohme LLC

Condiciones: Solid Tumors, Hematologic Malignancies

Sedes en Monterrey: Avix Investigación Clinica, S.C.-Oncology ( Site 1104) · I Can Oncology Center SA de CV ( Site 1116) · Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 1113)

Ver registro oficial ↗
ReclutandoNCT03899155

Pan Tumor Rollover Study

Fase 2Bristol-Myers Squibb

Condiciones: Cancer

Sedes en Monterrey: Local Institution - 0286 · Local Institution - 0354 · I Can Oncology Center

Ver registro oficial ↗
ReclutandoNCT04613596

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Fase 2 / Fase 3Mirati Therapeutics Inc.

Condiciones: Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

Sedes en Monterrey: Local Institution - Unk037 · Avix Investigacion Clinica · Local Institution - Unk026

Ver registro oficial ↗
ReclutandoNCT05899608

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Fase 3Summit Therapeutics

Condiciones: Non-Small Cell Lung Cancer

Sedes en Monterrey: Althian Clinical Research · Hospital Universitario "Dr. José Eleuterio González" · I Can Oncology Center

Ver ficha informativa
ReclutandoNCT06119581

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Fase 3Eli Lilly and Company

Condiciones: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Sedes en Monterrey: Hospital Universitario "Dr. Jose Eleuterio Gonzalez" · Avix Investigación Clinica, S.C.

Ver ficha informativa
ReclutandoNCT06136650

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Fase 3Merck Sharp & Dohme LLC

Condiciones: Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms

Sedes en Monterrey: Filios Alta Medicina ( Site 0931) · Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 0932) · Eukarya Pharmasite S.C. ( Site 0939)

Ver ficha informativa
ReclutandoNCT06750094

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Fase 3Janssen Research & Development, LLC

Condiciones: Colorectal Neoplasms

Sedes en Monterrey: Hospital Universitario Dr Jose Eleuterio Gonzalez

Ver registro oficial ↗
ReclutandoNCT06790693

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Fase 3Hoffmann-La Roche

Condiciones: Breast Cancer

Sedes en Monterrey: Hospital Zambrano Hellion TecSalud

Ver registro oficial ↗
ReclutandoNCT06824467

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Fase 3Merck Sharp & Dohme LLC

Condiciones: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

Sedes en Monterrey: Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" ( Site 1711) · I CAN ONCOLOGY CENTER S.A. DE C.V. ( Site 1716) · Servicios de Oncología Médica Integral - Monterrey ( Site 1712)

Ver registro oficial ↗
ReclutandoNCT06841354

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Fase 3Merck Sharp & Dohme LLC

Condiciones: Triple Negative Breast Neoplasms

Sedes en Monterrey: Filios Alta Medicina ( Site 2506) · Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" ( Site 2501)

Ver ficha informativa